Johnson & Johnson to buy Shockwave Medical for US$12.5 billion
Add BT as a preferred source
JOHNSON & Johnson will buy medical device maker Shockwave Medical for about US$12.5 billion, the companies said on Friday (Apr 5), helping the healthcare conglomerate boost its portfolio of medical devices.
The California-based company makes a device which uses shockwaves to break down calcified plaque in heart vessels, similar to how kidney stones are treated.
Under the deal, J&J would pay US$335 per share in cash for the medical device maker. The offer price implies a 4.7% premium to Shockwave’s last close of US$319.99 on Thursday.
Shockwave, a company that makes devices to treat heart disease, has a market capitalisation of about US$12 billion, according to LSEG data. REUTERS
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
TRENDING NOW
Hell hath no fury like a man scorned: CEO’s S$468,000 suit against ex fails after relationship sours
How Asia’s next generation is rewriting legacy through entrepreneurship
Singapore’s new data centres must use renewables. Can they overcome the hurdles?
Canada’s fight with the US has far bigger stakes than trade
